Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells.

Biochimica et biophysica acta. Reviews on cancer - 1 Aug 2021

Cai Jingshan, Cui Yudan, Yang Jun, Wang Shengjun

Abstract excerpt

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous myeloid cell population characterized by protumoral functions in the tumor immune network. An increasing number of studies have focused on the biological functions of MDSCs in tumor immunity. Epithelial-mesenchymal transition (EMT) is a cellular plasticity process accompanied by a loss of epithelial phenotypes and an acquisition of mesenchymal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Cell Plasticity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial-Mesenchymal Transition

Share to Immunotherapy

Share to Molecular Targeted Therapy

Share to Myeloid-Derived Suppressor Cells

Share to Tumor Escape

Share to Tumor Microenvironment

Source

Identifiers

PMID: 33974950
DOI: 10.1016/j.bbcan.2021.188564

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells.PMID 33974950Read ↗

Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.Semantic proximity Read ↗

Immunological Consequences of Epithelial–Mesenchymal Transition in Tumor ProgressionSemantic proximity Read ↗

The Epithelial-Mesenchymal Transition and Cancer Stem Cells: Functional and Mechanistic LinksSemantic proximity Read ↗

Factors Determining Epithelial-Mesenchymal Transition in Cancer ProgressionSemantic proximity Read ↗

Epithelial–mesenchymal transition in cancer development and its clinical significanceSemantic proximity Read ↗

Epithelial to Mesenchymal Transition in a Clinical PerspectiveSemantic proximity Read ↗

Update on Epithelial-Mesenchymal Plasticity in Cancer ProgressionSemantic proximity Read ↗

Epithelial Mesenchymal Transition in Aggressive Lung Cancers.Semantic proximity Read ↗

Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoeditingSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapySemantic proximity Read ↗

Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.